Skip to Content
Merck
CN

456764

3-Carboxyphenylboronic acid

≥95%

Synonym(s):

μ-Carboxyphenylboronic acid, 3-(Dihydroxyborane)benzoic acid, 3-(Dihydroxyboryl)benzoic acid, 3-Boronobenzoic acid, 3-Carboxybenzeneboronic acid

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
HO2CC6H4B(OH)2
CAS Number:
Molecular Weight:
165.94
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352103
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C7H7BO4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4,11-12H,(H,9,10)

SMILES string

OB(O)c1cccc(c1)C(O)=O

InChI key

DBVFWZMQJQMJCB-UHFFFAOYSA-N

assay

≥95%

mp

243-247 °C (lit.)

functional group

carboxylic acid

Quality Level

Application

3-Carboxyphenylboronic acid can be used as a substrate in the preparation of:
  • Biaryl derivatives by reacting with bromoaniline through the Suzuki-Miyaura coupling reaction.
  • Boronic acid-functionalized block copolymer.
  • 1H-Imidazo[1,2-a]quinoxaline derivatives.

Other Notes

Contains varying amounts of anhydride

Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Novel rhodamine dyes via Suzuki coupling of xanthone triflates with arylboroxins
Calitree, B. D.; Detty, M. R.
Synlett, 89-92 (2010)
Jumin Yang et al.
Materials science & engineering. C, Materials for biological applications, 116, 111250-111250 (2020-08-19)
Various nanoparticles as drug delivery system provide significant improvements in the cancer treatment. However, their clinical success remains elusive in large part due to their inability to overcome both systemic and tumor tissue barriers. The nanosystems with nanoproperty-transformability (surface, size
Christopher G Barber et al.
Bioorganic & medicinal chemistry letters, 14(12), 3227-3230 (2004-05-20)
A series of 1-isoquinolinylguanidines are shown to be potent inhibitors of uPA with selectivity over tPA and plasmin. Potency is enhanced by the presence of a 4-halo and a 7-aryl substituent, particularly when substituted by a 3-carboxylic acid group. Compound
Heterocycles, 60, 1891-1897 (2003)
New imidazo [1, 2-a] quinoxaline derivatives: synthesis and in vitro activity against human melanoma
Deleuze-Masquefa C, et al.
European Journal of Medicinal Chemistry, 44(9), 3406-3411 (2009)

Related Content

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service